GCG and type 2 diabetes mellitus: DPP4 is well studied for its degrading glucagon-like peptide 1 (GLP-1) and the treatment of type-2 diabetes (Demuth et al., 2005), as well as other signaling peptides including substance P (Mentlein, 1999), and there are several FDA approved drugs targeting DPP4.